• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

布地奈德的迟发性斑贴试验反应不一定是由试验程序诱导的致敏迹象。

Late patch-test reactions to budesonide need not be a sign of sensitization induced by the test procedure.

作者信息

Isaksson Marléne, Bruze Magnus

机构信息

Department of Occupational and Environmental Dermatology, Malmö University Hospital, Malmo, Sweden.

出版信息

Am J Contact Dermat. 2003 Sep;14(3):154-6. doi: 10.2310/6620.2003.6169.

DOI:10.2310/6620.2003.6169
PMID:14744407
Abstract

Patch-test sensitization may be suspected when a flare-up is seen at a test site at least 10 days after the test application. We describe two patients allergic to budesonide who were only diagnosed at patch-test readings on day 10 and day 13, respectively. The patients were patch-tested to a standard series including two corticosteroid mixes and their three constituents in petrolatum, namely, budesonide, tixocortol pivalate, and hydrocortisone-17-butyrate, at differing concentrations. In both patients, positive reactions to the mixes were seen on day 6 or day 7, but positive reactions to the budesonide preparations at 0.1% and 0.002% were not seen on the first or second ordinary reading day, day 3 or 4, and day 6 or 7, but no positive reactions to both budesonide preparations were seen on day 10 and on day 13, respectively. Not all late patch-test reactions represent patch-test sensitization, at least not to budesonide.

摘要

当在试验敷用后至少10天在试验部位出现皮疹时,可能怀疑是斑贴试验致敏。我们描述了两名对布地奈德过敏的患者,他们分别在第10天和第13天的斑贴试验读数时才被诊断出来。对这两名患者进行了斑贴试验,使用的是一个标准系列,包括两种皮质类固醇混合物及其在凡士林里的三种成分,即布地奈德、匹伐酸替可的松和丁酸氢化可的松-17,浓度各不相同。在这两名患者中,在第6天或第7天对混合物出现了阳性反应,但在第1次或第2次常规读数日,即第3或4天以及第6或7天,对0.1%和0.002%的布地奈德制剂未出现阳性反应,而分别在第10天和第13天对两种布地奈德制剂均未出现阳性反应。并非所有迟发性斑贴试验反应都代表斑贴试验致敏,至少对布地奈德而言并非如此。

相似文献

1
Late patch-test reactions to budesonide need not be a sign of sensitization induced by the test procedure.布地奈德的迟发性斑贴试验反应不一定是由试验程序诱导的致敏迹象。
Am J Contact Dermat. 2003 Sep;14(3):154-6. doi: 10.2310/6620.2003.6169.
2
Patch testing with corticosteroid mixes in Europe. A multicentre study of the EECDRG.欧洲使用皮质类固醇混合物进行斑贴试验。欧洲接触性皮炎研究组的一项多中心研究。
Contact Dermatitis. 2000 Jan;42(1):27-35. doi: 10.1034/j.1600-0536.2000.042001027.x.
3
Patch testing to detect corticosteroid allergy: is it adequate?用于检测皮质类固醇过敏的斑贴试验:是否足够?
Contact Dermatitis. 1997 Mar;36(3):127-30. doi: 10.1111/j.1600-0536.1997.tb00393.x.
4
Corticosteroid-induced contact dermatitis: a pragmatic approach.皮质类固醇诱发的接触性皮炎:一种实用方法。
Clin Exp Dermatol. 2000 Jun;25(4):261-4. doi: 10.1046/j.1365-2230.2000.00637.x.
5
The benefit of patch testing with a corticosteroid at a low concentration.
Am J Contact Dermat. 1999 Mar;10(1):31-3. doi: 10.1016/s1046-199x(99)90090-8.
6
Prevalence of contact allergy to corticosteroids in a Danish patient population.丹麦患者人群中接触性皮质类固醇过敏的流行率。
Contact Dermatitis. 2022 Sep;87(3):273-279. doi: 10.1111/cod.14135. Epub 2022 May 26.
7
Contact allergy to corticosteroids: Is the European baseline series sufficient?接触性皮质类固醇过敏:欧洲基本系列是否足够?
Contact Dermatitis. 2023 Oct;89(4):277-283. doi: 10.1111/cod.14358. Epub 2023 Jun 15.
8
Stability of corticosteroid patch test preparations.
Contact Dermatitis. 2000 Mar;42(3):144-8. doi: 10.1034/j.1600-0536.2000.042003144.x.
9
Corticosteroid contact hypersensitivity: what vehicle and concentration?皮质类固醇接触性超敏反应:何种载体及浓度?
Contact Dermatitis. 1996 May;34(5):305-8. doi: 10.1111/j.1600-0536.1996.tb02212.x.
10
Low yield for extended reading of patch tests with topical corticosteroids.外用皮质类固醇斑贴试验延长读数的阳性率低。
Dermatitis. 2005 Sep;16(3):124-6.

引用本文的文献

1
Extended fragrance ingredients surveillance study (EFISS)-protocol for a clinical surveillance study on contact allergy to 7 fragrance materials in widespread use but hitherto not systematically patch tested.扩展香料成分监测研究(EFISS)——一项关于对7种广泛使用但迄今未进行系统斑贴试验的香料材料接触性过敏的临床监测研究方案。
Arch Dermatol Res. 2025 May 23;317(1):778. doi: 10.1007/s00403-025-04286-9.